We offer comprehensive treatment programs for Health Care Professionals, patients, care takers and relatives that are much more than a tablet. We consolidate our commitment to them by offering safe, efficient, and affordable treatments as well as continuous medical education programs for Health Care Professionals including updated information on several diseases, their diagnose, and treatment. In addition, we offer guidance for care takers and patients for the purpose of improving their quality of life.
The Cardiometabolic Division of Silanes integrates a portfolio of products focusing on the control and treatment of conditions like high blood pressure and dyslipidemia so we can contribute to the decrease of deaths caused by the cardiovascular diseases affecting our country. The cardiovascular division takes care of the heart of Mexicans to create healthy life stories.
In the metabolic division of Silanes, we have a comprehensive drug products line that includes the effective treatment that best suits a specific condition like diabetes, prediabetes, overweight, obesity, and other insulin resistance states such as the polycystic ovary syndrome by ensuring a timely treatment for achieving a better quality of life for patients.
Central Nervous System
The central nervous system concentrates all mental activities including thoughts, learning, and memory. It can be altered by a wide range of diseases. With our line of products, we commit to improving the patients’ quality of life and clinical conditions by offering them treatments that are safe, efficient, and affordable.
Pain relief is a fundamental right for everybody which is why the relief of this discomfort must be efficient, accurate, and safe. We have a product portfolio that focuses in the relief of different pain intensities from pain killers, anti-inflammatory drugs, and antipyretics, to unique combinations existing in the market providing better results.
With innovation as our main tool to be competitive, we have become worldwide leaders in the research, development, and production of antivenoms to neutralize the venom from poisonous animals.
Silanes has created a new global generation of antivenoms which biotechnological features make them different and have earned them the name of fabotherapics.
These antivenoms have been recently described as highly safe and efficient drugs and no severe adverse reactions have been reported so far. Their manufacture is based on 100% inner technology which has patent protection in several countries.
The quality of our products is a fixed goal within our company which has allowed us to receive, for instance, a certification from COFEPRIS in México. In addition, Silanes is the only Mexican company to have obtained the “orphan drug” designation (absence of a drug or drug product to treat a specific condition) from the US Food and Drug Administration (FDA) for two of its products; this reinforces the global leadership role Silanes has in the development and production of fabotherapics.